18 research outputs found
ASSESSMENT OF PHYSICAL ACTIVITY IN AN OUTPATIENT OBESITY CLINIC IN SOUTHERN ITALY: RESULTS FROM A STANDARDIZED QUESTIONNAIRE.
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis
Gestione dietetico-nutrizionale dei pazienti con diabete tipo 2 e obesità sottoposti a interventi di chirurgia bariatrica
Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes.
Implementation of low glycemic index diet together with cornstarch in post-gastric bypass hypoglycemia: Two case reports
Post-bariatric hypoglycemia (PBH) is an increasingly recognized long-term complication of bariatric surgery. The nutritional treatment of PBH includes a high-fiber diet and the restriction of soluble and high-glycemic index carbohydrates; however, these measures are not always enough to prevent hypoglycemia. We evaluated the efficacy of uncooked cornstarch, a low-glycemic index carbohydrate characterized by slow intestinal degradation and absorption, in addition to a high-fiber diet, for the treatment of PBH. We report the cases of two young women suffering from severe postprandial and fasting hypoglycemia following Roux-en-Y gastric bypass (RYGB). The patients underwent Continuous Glucose Monitoring (CGM) before and 12⁻16 weeks after the administration of uncooked cornstarch (respectively 1.25 g/kg b.w. and 1.8 g/kg b.w.) in addition to a high-fiber diet. In both patients, CGM showed more stable glucose levels throughout monitoring, a remarkable reduction of the time spent in hypoglycemia
Bariatric surgery and long-term nutritional issues
Bariatric surgery is recognized as a highly effective therapy for obesity since it accomplishes sustained weight loss, reduction of obesity-related comorbidities and mortality, and improvement of quality of life. Overall, bariatric surgery is associated with a 42% reduction of the cardiovascular risk and 30% reduction of all-cause mortality. This review focuses on some nutritional consequences that can occur in bariatric patients that could potentially hinder the clinical benefits of this therapeutic option. All bariatric procedures, to variable degrees, alter the anatomy and physiology of the gastrointestinal tract; this alteration makes these patients more susceptible to developing nutritional complications, namely, deficiencies of macro- and micro-nutrients, which could lead to disabling diseases such as anemia, osteoporosis, protein malnutrition. Of note is the evidence that most obese patients present a number of nutritional deficits already prior to surgery, the most important being vitamin D and iron deficiencies. This finding prompts the need for a complete nutritional assessment and, eventually, an adequate correction of pre-existing deficits before surgery. Another critical issue that follows bariatric surgery is post-operative weight regain, which is commonly associated with the relapse of obesity-related co-morbidities. Nu-tritional complications associated with bariatric surgery can be prevented by life-long nutritional monitoring with the administration of multi-vitamins and mineral supplements according to the patient's needs
Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up
Bariatric surgery (BS) is known to favorably impact fasting lipid profile. Fasting and postprandial lipids were evaluated before and 2 years after BS in obese type 2 diabetic (T2DM) patients. Methods A prospective study was conducted in 19 obese T2DM patients: ten undergoing sleeve gastrectomy (SG) and nine undergoing Roux-en-Y gastric bypass (RYGB). Before and 2 years after BS, clinical parameters and the response of lipid and incretin hormones to a mixed meal (MM) were assessed. Results The two groups had similar characteristics at baseline.After BS, weight loss was similar in the two groups (p≤0.01). Fasting glucose, insulin, and triglycerides decreased while HDL cholesterol increased in a similar way (p<0.05); in contrast, fasting LDL cholesterol decreased only after RYGB (p<0.05). Post-meal glucose concentrations decreased while early insulin response significantly improved after both procedures (p<0.001 for both). Postprandial triglycerides decreased after both procedures (p<0.05) while postprandial LDL cholesterol decreased only after RYGB (p<0.05). Meal-GLP-1 increased postoperatively in both groups although to a greater extent after RYGB (p<0.001 vs. SG). GIP decreased after both procedures, especially after RYGB (p=0.003). At multivariate analysis, GLP-1 peak was the best predictor of LDL reduction (β=−0.552, p=0.039) while the improvement of HOMA-IR (β=0.574, p=0.014) and weight loss (β=0.418, p=0.036) predicted triglycerides reduction. Conclusions Both surgical procedures markedly reduce fasting and postprandial triglycerides and increase HDL cholesterol levels. LDL cholesterol decreases only after RYGB through a mechanism likely mediated by the restoration of GLP-1